Cite

HARVARD Citation

    Xu, G. et al. (2018). A highly potent and selective inhibitor Roxyl-WL targeting IDO1 promotes immune response against melanoma. Journal of enzyme inhibition and medicinal chemistry. pp. 1089-1094. [Online]. 
  
Back to record